FDA Issues Recall for Non-Sterile Eye Ointments Sold at CVS and Walmart
The US Food and Drug Administration (FDA) has issued a warning regarding the sterility of certain eye ointments available at CVS and Walmart, potentially posing a risk of eye infections. The recall, initiated by Brassica Pharma, was posted by the FDA on February 26, encompassing several eye ointments with expiration dates spanning from February 2024 to September 2025. According to the recall notice, an FDA inspection conducted at a Brassica facility uncovered a “lack of sterility assurance,” raising concerns about the possibility of eye infections resulting from product use. Recall Details and Health Risks: FDA’s Concerns Over Contaminated Eye Products This recall marks the latest in a series of FDA actions targeting eye products. In October of the previous year, the FDA cautioned consumers about 26 eye drop products linked to a serious eye infection, which could potentially lead to vision loss or blindness. The agency identified “unsanitary conditions in the manufacturing facili...